Contact: Summer Freeman
St. Jude Children's Research Hospital
Caption: The new screening approach developed by St. Jude involves identifying donors who make the most potent version of specialized immune cells called natural killer (NK) cells. Illustrated is an NK cell destroying a cancer cell.
Credit: Joshua Stokes, St. Jude Children's Research Hospital
Usage Restrictions: Use image with appropriate caption and credits.
Related news release: Immune system marker tied to improved bone marrow transplant outcomes